Yükleniyor... / Loading...
Encodes N-acetylgalactosamine-6-sulfatase enzyme. Mutations cause MPS IVA (Morquio A).
Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.